
Neeraj Sharma
Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2626 |
| Total Applications | 582 |
| Issued Applications | 475 |
| Pending Applications | 51 |
| Abandoned Applications | 71 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9737315
[patent_doc_number] => 20140273033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'BIOMARKERS FOR MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/290782
[patent_app_country] => US
[patent_app_date] => 2014-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18283
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14290782
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/290782 | BIOMARKERS FOR MULTIPLE SCLEROSIS | May 28, 2014 | Abandoned |
Array
(
[id] => 10946913
[patent_doc_number] => 20140349934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'METHOD FOR INDUCING TWIN CALVING'
[patent_app_type] => utility
[patent_app_number] => 14/285541
[patent_app_country] => US
[patent_app_date] => 2014-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2002
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14285541
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/285541 | Method for inducing twin calving | May 21, 2014 | Issued |
Array
(
[id] => 10305459
[patent_doc_number] => 20150190459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'Method Of Reducing Injury To Mammalian Cells'
[patent_app_type] => utility
[patent_app_number] => 14/279243
[patent_app_country] => US
[patent_app_date] => 2014-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 29584
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14279243
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/279243 | Method Of Reducing Injury To Mammalian Cells | May 14, 2014 | Abandoned |
Array
(
[id] => 10926721
[patent_doc_number] => 20140329742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'THERAPEUTIC PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/265831
[patent_app_country] => US
[patent_app_date] => 2014-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14265
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14265831
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/265831 | Peptide YY analogs | Apr 29, 2014 | Issued |
Array
(
[id] => 9736156
[patent_doc_number] => 20140271868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'TREATMENT OF ACHONDROPLASIA WITH ENCAPSULATED CNP-SECRETING CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/255773
[patent_app_country] => US
[patent_app_date] => 2014-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11015
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14255773
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/255773 | TREATMENT OF ACHONDROPLASIA WITH ENCAPSULATED CNP-SECRETING CELLS | Apr 16, 2014 | Abandoned |
Array
(
[id] => 10728171
[patent_doc_number] => 20160074320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'PHARMACEUTICAL COMPOSTIONS COMPRISING KISSPEPTIN OR DERIVATIVES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/783476
[patent_app_country] => US
[patent_app_date] => 2014-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2926
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14783476
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/783476 | PHARMACEUTICAL COMPOSTIONS COMPRISING KISSPEPTIN OR DERIVATIVES THEREOF | Apr 8, 2014 | Abandoned |
Array
(
[id] => 10919218
[patent_doc_number] => 20140322237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'NEURODEGENERATIVE DISEASES AND METHODS OF MODELING'
[patent_app_type] => utility
[patent_app_number] => 14/244554
[patent_app_country] => US
[patent_app_date] => 2014-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 23753
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14244554
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/244554 | NEURODEGENERATIVE DISEASES AND METHODS OF MODELING | Apr 2, 2014 | Abandoned |
Array
(
[id] => 9615761
[patent_doc_number] => 20140205618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'HUMAN FERTILITY ENHANCEMENT WITH CORTISOL REDUCTION FOOD'
[patent_app_type] => utility
[patent_app_number] => 13/999875
[patent_app_country] => US
[patent_app_date] => 2014-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3090
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13999875
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/999875 | HUMAN FERTILITY ENHANCEMENT WITH CORTISOL REDUCTION FOOD | Mar 28, 2014 | Abandoned |
Array
(
[id] => 10693771
[patent_doc_number] => 20160039917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'Method for Treating Eclampsia and Preeclampsia'
[patent_app_type] => utility
[patent_app_number] => 14/777483
[patent_app_country] => US
[patent_app_date] => 2014-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 27491
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14777483
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/777483 | Method for Treating Eclampsia and Preeclampsia | Mar 16, 2014 | Abandoned |
Array
(
[id] => 10657694
[patent_doc_number] => 20160003838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSING PREECLAMPSIA'
[patent_app_type] => utility
[patent_app_number] => 14/774776
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 19047
[patent_no_of_claims] => 89
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774776
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/774776 | METHODS AND COMPOSITIONS FOR DIAGNOSING PREECLAMPSIA | Mar 13, 2014 | Abandoned |
Array
(
[id] => 9757255
[patent_doc_number] => 20140287950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH'
[patent_app_type] => utility
[patent_app_number] => 14/213861
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 51259
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14213861
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/213861 | BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH | Mar 13, 2014 | Abandoned |
Array
(
[id] => 10676628
[patent_doc_number] => 20160022773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH'
[patent_app_type] => utility
[patent_app_number] => 14/775386
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16204
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775386
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/775386 | Methods for promoting wound healing and hair growth comprising GDNF administration | Mar 13, 2014 | Issued |
Array
(
[id] => 10679594
[patent_doc_number] => 20160025739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'PRE-ECLAMPSIA BIOMARKERS'
[patent_app_type] => utility
[patent_app_number] => 14/773677
[patent_app_country] => US
[patent_app_date] => 2014-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 25652
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773677
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/773677 | Pre-eclampsia biomarkers | Mar 11, 2014 | Issued |
| 14/203317 | HUMAN PAC1 ANTIBODIES | Mar 9, 2014 | Abandoned |
Array
(
[id] => 10593428
[patent_doc_number] => 09314499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-19
[patent_title] => 'Annexin A2 and tissue plasminogen activator for treating vascular disease'
[patent_app_type] => utility
[patent_app_number] => 14/197988
[patent_app_country] => US
[patent_app_date] => 2014-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 5
[patent_no_of_words] => 17457
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14197988
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/197988 | Annexin A2 and tissue plasminogen activator for treating vascular disease | Mar 4, 2014 | Issued |
Array
(
[id] => 10679593
[patent_doc_number] => 20160025738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'PROGNOSTIC MARKER TO DETERMINE THE RISK FOR EARLY-ONSET PREECLAMPSIA'
[patent_app_type] => utility
[patent_app_number] => 14/772893
[patent_app_country] => US
[patent_app_date] => 2014-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13149
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14772893
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/772893 | PROGNOSTIC MARKER TO DETERMINE THE RISK FOR EARLY-ONSET PREECLAMPSIA | Mar 2, 2014 | Abandoned |
Array
(
[id] => 10489796
[patent_doc_number] => 20150374817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF BURNOUT SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 14/769716
[patent_app_country] => US
[patent_app_date] => 2014-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3806
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14769716
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/769716 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF BURNOUT SYNDROME | Feb 20, 2014 | Abandoned |
Array
(
[id] => 9538305
[patent_doc_number] => 20140162953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'USE OF INHALABLE POWDER FORMULATION COMPRISING GROWTH HORMONE FOR PREVENTING OR TREATING NMDA RECEPTOR HYPOFUNCTION-RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/180677
[patent_app_country] => US
[patent_app_date] => 2014-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7179
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14180677
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/180677 | Use of inhalable powder formulation comprising growth hormone for preventing or treating NMDA receptor hypofunction-related diseases | Feb 13, 2014 | Issued |
Array
(
[id] => 10468870
[patent_doc_number] => 20150353886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'SALIVARY ESTRADIOL DETECTION METHODS AND USES FOR MONITORING OVULATION AND FERTILITY, AND SELECTION OR TIMING OF EGG RETRIEVAL AND/OR FERTILIZATION'
[patent_app_type] => utility
[patent_app_number] => 14/763627
[patent_app_country] => US
[patent_app_date] => 2014-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10966
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14763627
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/763627 | SALIVARY ESTRADIOL DETECTION METHODS AND USES FOR MONITORING OVULATION AND FERTILITY, AND SELECTION OR TIMING OF EGG RETRIEVAL AND/OR FERTILIZATION | Jan 29, 2014 | Abandoned |
Array
(
[id] => 9634783
[patent_doc_number] => 20140212891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'Compositions and Methods Using NOX5'
[patent_app_type] => utility
[patent_app_number] => 14/167396
[patent_app_country] => US
[patent_app_date] => 2014-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9784
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14167396
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/167396 | Compositions and Methods Using NOX5 | Jan 28, 2014 | Abandoned |